Professional Experience

IDEC Pharmaceuticals

Vice President of Research and Director

Pharmacyclics

Founder & CEO

Principia Biopharma

Board Member

Graphea

President and CEO

Graphea present
SimplePons, Inc.

VP

SimplePons, Inc. February 2011 – present

Affiliations

3M

3M Saint Paul, Minnesota, United States
Benedict College

Benedict College Columbia, South Carolina, United States
Boston Children's Hospital

Boston Children's Hospital Boston, Massachusetts, United States
Boston University

Boston University Boston, Massachusetts, United States
Elopak Systems

Elopak Systems Glattbrugg, Zurich, Switzerland
Harvard University

Harvard University Cambridge, Massachusetts, United States
IDEC Pharmaceutical

IDEC Pharmaceutical San Diego, California, United States
Monarch Marking Systems

Monarch Marking Systems Dayton, Ohio, United States
Ohio State University Moritz College of Law

Ohio State University Moritz College of Law Columbus, Ohio, United States
Paxar Americas

Paxar Americas Miamisburg, Ohio, United States
Saint Michael's Medical Center

Saint Michael's Medical Center Newark, New Jersey, United States
Southern Illinois University

Southern Illinois University Carbondale, Illinois, United States
Translational Genomics Research Institute (TGen)

Translational Genomics Research Institute (TGen) Phoenix, Arizona, United States
University of Alabama Huntsville

University of Alabama Huntsville Huntsville, Alabama, United States
University of Michigan School of Information

University of Michigan School of Information Ann Arbor, Michigan, United States
University of New Hampshire

University of New Hampshire Durham, New Hampshire, United States
University of Texas System

University of Texas System Austin, Texas, United States
Portfolio Summary
396 documents
  • Research Grants 221 view all grants

    $1.4M
    2015

    $1.4M
    2016

    $1.4M
    2017

    $1.4M
    2018

    $2M
    2019
  • Publications 6 view all publications
    • 1
      Antibodies, Monoclonal/administration & dosage
    • 1
      Antineoplastic Agents/pharmacology
    • 1
      Antineoplastic Combined Chemotherapy Protocols/therapeutic use
    • 1
      Apoptosis/drug effects
    • 1
      Hydrogen Sulfide/metabolism
    • 1
      Hypothalamo-Hypophyseal System/metabolism
    • 1
      Liver/metabolism
    • 1
      Lymphoma, Non-Hodgkin/drug therapy
    • 1
      Lymphoma, Non-Hodgkin/radiotherapy
    • 1
      Metalloporphyrins/administration & dosage
  • Patents 169view all patents
    • 52
      A61K - Preparations for medical, dental, or toilet purposes
    • 35
      G02B - Optical elements, systems, or apparatus
    • 26
      C07D - Heterocyclic compounds
    • 23
      B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry
    • 18
      C07H - Sugars
    • 17
      A61L - Methods or apparatus for sterilising materials or objects in general
    • 11
      G02F - Devices or arrangements, the optical operation of which is modified by changing the optical properties of the medium of the devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light, e.g. switching, gating, modulating or demodulating
    • 10
      F21V - Functional features or details of lighting devices or systems thereof
    • 8
      F21S - Non-portable lighting devices
    • 5
      A61N - Electrotherapy